Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2025-12-24 @ 4:59 PM
NCT ID:
NCT01472250
Eligibility Criteria:
Inclusion Criteria:
1. The patient has histologically confirmed locally-advanced or recurrent and/or metastatic gastric or esophagogastric junction adenocarcinoma, has missed the opportunity of surgical excision, making curative therapy impossible.
2. The informed consent form is signed.
3. A specimen of tumor tissue (puncture biopsy or surgical specimen) is available.
4. ECOG performance status is 0, 1 or 2.
5. The patient's general conditions and functions of important organs allow generalized chemotherapy according to the investigator's judgment
6. The patient is agedā„18
Exclusion Criteria:
1. The patient is known to be allergic to any study drug.
2. The patient is recruited in other clinical study or is planned to participate into other clinical study.
3. The patient has previously accepted chemotherapy against advanced or metastatic diseases (the patient may be recruited if the previous adjuvant therapy/neoadjuvant therapy was completed more than 6 months before inclusion).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT01472250
Study Brief:
Protocol Section:
NCT01472250